Evaluation of Clinical Perfectionism in Parkinson Disease (EPMP-1)

August 20, 2018 updated by: Centre Hospitalier Universitaire, Amiens
Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety. Also, clinicians reported that they exhibit specific personality traits (e.g., rigidity and perfectionism).

To date, few studies used Cognitive Behavioural Therapies (CBT) in people with Parkinson's disease showing promising results. Recently, perfectionism has received particular attention because of it association with many emotional disorders. Thus, some psychometric tools have been developed in order to evaluate different aspects of perfectionism. Yet, none of them has been used in people with Parkinson's disease.

The objective of this study is to investigate whether there is a direct link between Parkinson's disease and perfectionism by using psychometric tools from the CBT literature. Identifying such link would allow to justify the use of CBT in people with Parkinson's disease with the goal in mind to improve their care and quality of life.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Amiens, France, 80054
        • CHU Amiens

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age greater than 18 years
  • Score Mini Mental Scale (MMS) greater than 23
  • For Parkinsonian, Parkinson disease be defined according to the criteria of the Unified Parkinson Disease Rating Scale (UPDRS), with a Hoehn and Yahr stage 1, 2 or 3
  • The control patients present dystonias not within the scope of Parkinson
  • Informed Consent Form signed
  • Patient covered by social insurance

Exclusion Criteria:

  • Proven Presence of neuropsychological disorders
  • Patients with deep brain stimulation
  • Diagnosis of somatic pathology diagnosed
  • Private Patient freedom or protected adult (under guardianship)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Parkinsonian
Patient Arm: Parkinsonian will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Behavioral: Completion of scales evaluation
Patient complete scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS), Hewitt Multidimensional Perfectionism Scale (HMPS), scores to depression scale (Beck Depression Inventory (BDI)) and anxiety scale (State Trait Anxiety Inventory (STAI))
OTHER: Dystonic
Comparator Arm: Dystonic patient will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Behavioral: Completion of scales evaluation
Patient complete scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS), Hewitt Multidimensional Perfectionism Scale (HMPS), scores to depression scale (Beck Depression Inventory (BDI)) and anxiety scale (State Trait Anxiety Inventory (STAI))

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perfectionism evaluation 1
Time Frame: Day 0
Scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS)
Day 0
Perfectionism evaluation 2
Time Frame: Day 0
Hewitt Multidimensional Perfectionism Scale (HMPS).
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression and anxiety evaluation 1
Time Frame: Day 0
Scores to depression scale (Beck Depression Inventory (BDI))
Day 0
Depression and anxiety evaluation 2
Time Frame: Day 0
anxiety scale (State Trait Anxiety Inventory (STAI))
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Universitaire, Amiens

Investigators

  • Principal Investigator: Pierre KRYSTKOWIAK, MD, PhD, CHU Amiens

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 6, 2014

Primary Completion (ANTICIPATED)

August 1, 2018

Study Completion (ANTICIPATED)

August 1, 2018

Study Registration Dates

First Submitted

April 22, 2014

First Submitted That Met QC Criteria

July 1, 2016

First Posted (ESTIMATE)

July 6, 2016

Study Record Updates

Last Update Posted (ACTUAL)

August 21, 2018

Last Update Submitted That Met QC Criteria

August 20, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PI2014_843_0002
  • 2013-A01302-43 (OTHER: ID-RCB)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Completion of scales evaluation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe